0001104659-23-079110.txt : 20230707
0001104659-23-079110.hdr.sgml : 20230707
20230707160600
ACCESSION NUMBER: 0001104659-23-079110
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230424
FILED AS OF DATE: 20230707
DATE AS OF CHANGE: 20230707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Litchman Manuel MD
CENTRAL INDEX KEY: 0001709485
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38191
FILM NUMBER: 231076829
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MUSTANG BIO, INC.
CENTRAL INDEX KEY: 0001680048
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473828760
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 377 PLANTATION STREET
CITY: WORCESTER
STATE: MA
ZIP: 01605
BUSINESS PHONE: 7816524500
MAIL ADDRESS:
STREET 1: 377 PLANTATION STREET
CITY: WORCESTER
STATE: MA
ZIP: 01605
4
1
tm2320790-1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-04-24
0
0001680048
MUSTANG BIO, INC.
MBIO
0001709485
Litchman Manuel MD
377 PLANTATION STREET
WORCESTER
MA
01605
1
1
0
0
President and CEO
0
COMMON STOCK, PAR VALUE $0.0001
2023-04-24
4
A
0
5000
0.000
A
111079
D
Represents an award of 5,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2027.
Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Includes restricted share units, which vest over various time periods.
/s/ Matthew Wein, Attorney-in-Fact
2023-07-07